EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances in Cytotoxicity Testing: From In Vitro Assays to In Silico Models

Barbara Ziemba iD

International Journal of Molecular Sciences · 19.11.2025 · 26 (22) · 11202

DOI: 10.3390/ijms262211202 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 19.11.2025. Verfasst von Barbara Ziemba. Beteiligte Einrichtung: Department of General Biophysics, Faculty of Biology and Environmental Protection, University of Lodz, 141/143 Pomorska St., 90-236 Lodz, Poland. Hauptthemen laut MEDLINE: Computer Simulation, Toxicity Tests. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 252 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cytotoxicity testing remains a cornerstone of modern toxicology, providing critical insight into how chemicals and drugs affect cell viability and function. Classical colorimetric assays such as MTT, LDH release, and neutral red uptake established the methodological basis of in vitro toxicology and continue to serve as regulatory benchmarks. However, their limited mechanistic depth and physiological relevance have prompted the field to evolve towards more predictive and human-centred approaches. Recent advances in high-content imaging, flow cytometry, and real-time impedance analysis have transformed cytotoxicity testing into a multiparametric discipline capable of detecting adaptive and sub-lethal cellular responses. Parallel progress in computational toxicology has introduced in silico models—QSAR, machine learning, and physiologically based pharmacokinetic (PBPK) modelling—that enable quantitative in vitro–in vivo extrapolation (QIVIVE). The integration of these computational tools with 3D organoids, organ-on-chip systems, and stem cell-based models allows for cross-validation between predictive simulations and experimental evidence, enhancing mechanistic interpretation and translational accuracy. Together, these developments underpin New Approach Methodologies (NAMs) and Integrated Approaches to Testing and Assessment (IATA), marking the transition from descriptive assays to predictive, mechanism-anchored frameworks that bridge in silico prediction with in vitro and in vivo validation—advancing both biomedical research and regulatory toxicology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Computer SimulationToxicity TestsHumansAnimalsQuantitative Structure-Activity RelationshipModels, BiologicalMachine LearningCell Survival

Stichwörter der Autor:innen

3D cell culturecytotoxicity assayshigh-content imagingin silico modelsintegrated testing strategies (IATA)organ-on-a-chiptoxicity testing

Autor:innen und Institutionen

  • Department of General Biophysics, Faculty of Biology and Environmental Protection, University of Lodz, 141/143 Pomorska St., 90-236 Lodz, Poland.

ORCID-Profile: Barbara Ziemba

Zitieren

APA

Ziemba, B. (2025). Advances in Cytotoxicity Testing: From In Vitro Assays to In Silico Models. International Journal of Molecular Sciences, 26(22), 11202. https://doi.org/10.3390/ijms262211202

Vancouver

Ziemba B. Advances in Cytotoxicity Testing: From In Vitro Assays to In Silico Models. International Journal of Molecular Sciences. 2025;26(22):11202. doi:10.3390/ijms262211202

BibTeX
@article{Ziemba2025,
  author = {Ziemba, Barbara},
  title = {Advances in Cytotoxicity Testing: From In Vitro Assays to In Silico Models},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {22},
  pages = {11202},
  doi = {10.3390/ijms262211202}
}
Kostenlos starten →